GlaxoSmithKline is opening a £10 million artificial intelligence (AI) research hub in King’s Cross, London ... drain on the industry. GSK’s site will house 30 scientists and engineers ...
Hosted on MSN3mon
GSK moves to new HQ in return to central LondonIt marks the end of its time at the Brentford site in west London after the £315 million building was officially opened in 2002 by then prime minister Tony Blair. GSK’s new HQ will house the ...
News Shopper on MSN5h
The 'elite' Indian restaurant in London that's loved by Ed SheeranUse precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Expect fleet-footed waiters in stiff collars, paper tablecloths, pichets of decent house wine ... duo who dual-handedly defined London's restaurant scene for a decades-long stint split by the ...
GlaxoSmithKline (GSK) is to collaborate with the Francis Crick Institute, a new powerhouse of academic- and charity-funded biomedical research based in London. The new partnership is expected to ...
Shares in GSK (UK:GSK), listed on the London Stock Exchange, increased 5% on Thursday having gained 4% in the year-to-date. GSK's settlement, which was made without any admission of liability ...
Pfizer (PFE.N), opens new tab on Monday won a bid in a London court to invalidate two of GSK's (GSK.L), opens new tab patents relating to a respiratory syncytial virus (RSV) vaccine. The two ...
GSK GSK0.69%increase ... Shares rose 5.6% in morning trade in London, recovering to levels seen a year ago.
All eyes will be on the London stock market when trading resumes today after GSK shares rose in New York last night following the landmark update. GSK and rivals including Pfizer and Sanofi have ...
check out our weekly restaurant recommendation via the Esquire Junk Mail newsletter). Cuisine: French-British Location: Soho (49 Dean St, London W1D 5BG) Price: ££ The French House reservations ...
(Sharecast News) - London stocks rose in early trade on Thursday ... is scheduled for release at 1330 BST. In corporate news, GSK surged after agreeing to pay $2.2bn to settle about 80,000 ...
In another positive development, Pfizer won a bid in a London court to invalidate two of GSK Plc’s (NYSE:GSK) patents relating to its respiratory syncytial virus (RSV) vaccine. Also Read: UK Chooses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback